CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
4.870
-0.010 (-0.20%)
At close: Mar 12, 2026, 4:00 PM EDT
4.890
+0.020 (0.41%)
After-hours: Mar 12, 2026, 7:16 PM EDT
CytomX Therapeutics Market Cap
CytomX Therapeutics has a market cap or net worth of $825.15 million as of March 12, 2026. Its market cap has increased by 1,422.42% in one year.
Market Cap
825.15M
Enterprise Value
687.12M
1-Year Change
1,422.42%
Ranking
Category
Stock Price
$4.87
Market Cap Chart
Since October 8, 2015, CytomX Therapeutics's market cap has increased from $7.40M to $825.15M, an increase of 11,050.68%. That is a compound annual growth rate of 57.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 826.80M | 14.55% |
| Dec 31, 2025 | 721.80M | 795.53% |
| Dec 31, 2024 | 80.60M | -22.35% |
| Dec 29, 2023 | 103.80M | -1.80% |
| Dec 30, 2022 | 105.70M | -62.58% |
| Dec 31, 2021 | 282.50M | -6.70% |
| Dec 31, 2020 | 302.80M | -19.81% |
| Dec 31, 2019 | 377.60M | -44.44% |
| Dec 31, 2018 | 679.60M | -16.18% |
| Dec 29, 2017 | 810.80M | 102.65% |
| Dec 30, 2016 | 400.10M | -46.78% |
| Dec 31, 2015 | 751.80M | 10,059.46% |
| Oct 8, 2015 | 7.40M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Annexon | 842.17M |
| MannKind | 841.11M |
| Janux Therapeutics | 838.87M |
| ARS Pharmaceuticals | 836.08M |
| Phathom Pharmaceuticals | 836.05M |
| Arvinas | 823.18M |
| Evommune | 823.02M |
| Sana Biotechnology | 817.95M |